Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study - Quiz - MDSpire

Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study

  • By

  • Huiwen Sun

  • Jinhan Chen

  • Qian Xu

  • Chen Chen

  • Jinsheng Yu

  • Qijin Shu

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study

  • by Huiwen Sun, Jinhan Chen, Qian Xu, Chen Chen, Jinsheng Yu, Qijin Shu

  • May 25, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship